Siddharth Mittal: Transfusion Medicine as the Gateway to Cell and Gene Therapy
Siddharth Mittal, Assistant Professor at Aiims Jodhpur, shared a post on LinkedIn:
“I can’t emphasise this enough.
Transfusion medicine is increasingly the gateway into cellular and gene therapy, and the field is advancing fast – much of the cutting-edge science, regulatory thinking, and manufacturing work is happening internationally.
If you get the chance to immerse yourself in that environment, take it.
Seek out these opportunities, apply for the grants, make the case to your institutions.
The investment pays back many times over.
On that note, I feel fortunate to have been selected for an ESACT Academia Grant last year to attend the 5th edition of the ESACT Bioprocessing and Manufacturing of Gene and Cell Therapy Products Course in Llafranc, Spain.
It was an educational course – 30 hours of lectures and case analysis with an outstanding faculty – that set a strong conceptual base in gene and cell therapy bioprocessing.
For anyone building their foundation here, I’d recommend it without hesitation.
My thanks to the course coordinators and the ESACT team.
To those early in their careers: keep an eye out for programmes like this one.”

Stay updated with Hemostasis Today.
-
Sep 22, 2026, 19:02Blocking Histone-Induced Platelet-Erythrocyte Interactions With Polyanions – Platelets Journal
-
Sep 22, 2026, 18:49Abdul Rahman Hamad: Early Action for Better Outcomes in Deep Vein Thrombosis
-
Sep 22, 2026, 18:37Carmine Siniscalchi: Age-Adjusted D-Dimer Cutoffs in DVT Diagnosis
-
Sep 22, 2026, 18:37Stefano Romeo: The Cardiovascular Patient Journey is Still Full of Gaps
-
Sep 22, 2026, 18:11Bharath Kumar V.։ Advancing Safer Anticoagulation for Cancer-Associated Thrombosis
-
Sep 22, 2026, 18:10Fatima Zahra: ASH Released New Guidelines on the Diagnosis of Iron Deficiency
-
Sep 22, 2026, 17:49Nirav Dhanesha: Targeting FXI for Safer Anticoagulation
-
Sep 22, 2026, 17:17Eric Lambert: Intravascular Imaging and the Future of Precision PCI
-
Sep 22, 2026, 16:45Claudiu Stoicescu: Are We Starting Cardiovascular Risk Assessment Too Late?